Industrial Biotechnology China News 1107
|Published: July, 2011
Price: US $2,325
Enterprisewide/corporate license, per year – US$ 5,813.00
In this issue, we reveal some existing problems in the Chinese biofuel industry below: the industry lacks an efficient approach to collect the abundant cellulosic resources; the planting of Jatropha Curcas for biodiesel production still develops slowly in China; why ethanol gasoline is hard to be promoted in Guangxi. In the bio-product and bio-chemical part, we report DSM officially launched its joint venture in China for enzyme preparation business and the eye-catching patent dispute of LDA technology between Cathay and Shandong Hilead. At last, we illustrate the import & export trade for China’s PLA resin and report the PBS facility relocation might probably affect Zhejiang Xinfu’s profitability for one or two years.
Chinese bio-energy industry lacks an efficient way to collect cellulosic resources
Planting of Jatropha Curcas develops slowly in China
Shandong Longlive selected as state-appointed producer of fuel ethanol
Zhengzhou guarantees its raw material supply to develop biodiesel industry
Guangxi COFCO resumes production of fuel ethanol
DSM launches joint venture of enzyme preparation in China
Shandong University succeeded in 5-ALA production through fermentation process
Cathay requires to suspend its LDA production
Dongbao Bio-tech plans to construct a collagen production line
PBS facility relocation affects Zhejiang Xinfu’s profitability
Chinese PPC resin industry facing challenges
Trade analysis of China’s PLA resin
National Bio-energy Group Co., Ltd.
South China Botanical Garden affiliated to Chinese Academy of Sciences
Shandong Longlive Bio-technology Co., Ltd.
Guangxi COFCO Biomass Energy Co., Ltd.
Cathay Industrial Biotech Ltd.
Shandong Hilead Biotechnology Co., Ltd.
Baotou Dongbao Bio-tech Co., Ltd.
Zhejiang Hangzhou Xinfu Pharmaceutical Co., Ltd.
Inner Mongolia Mengxi High-Tech Group Co., Ltd.